Steen Stender

Steen Stender

Affiliate Professor

ORCID: 0000-0003-1037-1158

Publication year:
All
1 - 6 out of 6Page size: 50
  1. 2008
  2. Published

    Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial

    Due, A. P., Larsen, T. M., Mu, Huiling, Hermansen, K., Stender, Steen & Astrup, A., 2008, In: American Journal of Clinical Nutrition. 88, 5, p. 1232-1241 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monosaturated-fat, low-fat, and control diets

    Due, A. P., Larsen, T. M., Hermansen, K., Stender, Steen, Holst, Jens Juul, Toubro, S., Martinussen, Torben & Astrup, A., 2008, In: American Journal of Clinical Nutrition. 87, 4, p. 855-862 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Comparison of the effects on insulin resistance and glucose tolerance of 6-mo high-monounsaturated-fat, low-fat, and control diets

    Due, A. P., Larsen, T. M., Hermansen, K., Stender, Steen, Holst, Jens Juul, Toubro, S., Martinussen, Torben & Astrup, A., 2008, In: American Journal of Clinical Nutrition. 87, 4, p. 855-862 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Nutrition transition and its relationship to the development of obesity and related chronic diseases

    Astrup, A., Dyerberg, J., Selleck, M. & Stender, Steen, 2008, In: Obesity Reviews. 9, Suppl. 1, p. 48-52 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Ruminant and industrially produced trans fatty acids: health aspects

    Stender, Steen, Astrup, A. & Dyerberg, J., 2008, In: Food & Nutrition Research. 52, 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance

    Schuster, H., Fagerberg, B., Edwards, S., Halmos, T., Lopatynski, J., Stender, Steen, Birketvedt, G. S., Tonstad, S., Gause-Nilsson, I., Halldorsdottir, S. & Ohman, K. P., 2008, In: Atherosclerosis. 197, 1, p. 355-362 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 10820018